SF3B1PDAC.

Patrik Simmler1,2, Eleonora I Ioannidi2, Tamara Mengis2

  • 1Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.

eLife
|October 12, 2023
PubMed
概括

SF3B1K700E突变驱动胰腺癌的攻击性,特别是KRAS和p53突变. 这种拼接因子阻碍了TGF-β1的产生.